Robin H. Bogner
Professor/Pharmaceutical Science

Are you Robin H. Bogner?

How to update your information.
Grants

94 Grants

A Phase I Study of the Biomarker Response and Pharmacokinetic Profile of Thryotropin-Releasing Hormone (TRH) Administered as a Sublingual Tablet
Sponsor: Connecticut Innovations/University of Connecticut Health Center
Authors: Robin H Bogner
2015-01-01 - 2015-12-31
Development of a Sublingual TRH Tablet as a Novel Treatment for Cancer Fatigue
Sponsor: DHHS/NIH/National Institutes of Health/TRH Therapeutics
Authors: Robin H Bogner
2012-01-01 - 2012-06-30
Predictive Methods for Characterizing Product Performance in Pediatric Patients, Case Study: Furosemide
Sponsor: DHHS/FDA/Food and Drug Administration/National Institute of Pharmaceutical Technology and Education
Authors: Robin H Bogner
2014-01-01 - 2016-12-31
National Center for Pediatric Oncology Formulations (NCPOF)
Sponsor: DHHS/NIH/National Institutes of Health/National Institute of Pharmaceutical Technology and Education
Authors: Robin H Bogner
2010-08-31 - 2013-08-30
Aerogels for Improved Bioavailability of Orally-Ingested Drugs
Sponsor: NSF/ENG/Directorate for Engineering/Aspen Aerogels
Authors: Robin H Bogner
2012-07-01 - 2012-12-31
Chemical Stability of Amorphous Drugs in the Presence of Silicates
Sponsor: Parenteral Drug Association
Authors: Robin H Bogner
2006-06-01 - 2007-05-31
Formation of National Center for Pediatric Formulation
Sponsor: DHHS/NIH/National Institutes of Health/National Institute of Pharmaceutical Technology and Education
Authors: Robin H Bogner
2009-10-01 - 2011-09-30
Investigating the Effects of Hydrated Glass Transition Temperature and Degree of Supersaturation on Crystallization of Amorphous Drugs During Dissolution
Sponsor: American Foundation for Pharmaceutical Education
Authors: Robin H Bogner
2015-09-01 - 2016-08-03
Nanoporous Mono- and Multi-component Forms for Solubility Enhancement of Poor Water-soluble Drugs
Sponsor: NSF/National Science Foundation/CRDF Global
Authors: Robin H Bogner
2011-09-01 - 2013-08-31
A Phase I Study of the Biomarker Response and Pharmacokinetic Profile of the TRH Administered as a Sublingual Tablet
Sponsor: University of Connecticut Health Center
Authors: Robin H Bogner
2016-07-01 - 2017-06-30
AFPE Fellowship for Ken Qian
Sponsor: American Foundation for Pharmaceutical Education
Authors: Robin H Bogner
2010-09-01 - 2011-08-31
Effect of Hydrodynamics on Solution Mediated Phase Transformation of Pharmaceutical Compounds
Sponsor: American Foundation for Pharmaceutical Education
Authors: Robin H Bogner
2006-09-01 - 2007-05-31
Evaluating Different Methods for Preparing Biorelevant Media to Understand and Minimize Variation of In Vitro Solubility and Dissolution Testing
Sponsor: United States Pharmacopeial Convention
Authors: Robin H Bogner
2012-09-01 - 2014-08-31
REU Site in Pharmaceutical Sciences at the University of Connecticut
Sponsor: NSF/MPS/Directorate for Mathematical and Physical Sciences
Authors: Robin H Bogner
2007-01-01 - 2009-12-31
Evaluating Different Methods for Preparing Biorelevant Media to Understand and Minimize Variation of in Vitro Solubility and Dissolution Testing
Sponsor: United States Pharmacopeial Convention
Authors: Robin H Bogner
2011-09-01 - 2012-05-31
Excipient Functionality - Effect of Silicates on Amorphous Drug Stability and Dissolution
Sponsor: United States Pharmacopeial Convention
Authors: Robin H Bogner
2006-09-01 - 2007-08-31
Aerogels for Improved Bioavailability of Orally-Ingested Drugs
Sponsor: NSF/ENG/Directorate for Engineering/Aspen Aerogels
Authors: Robin H Bogner
2013-01-01 - 2013-06-30
Aerogels for Improved Bioavailibility of Orally-Ingested Drugs
Sponsor: NSF/ENG/Directorate for Engineering/Aspen Aerogels
Authors: Robin H Bogner
2013-07-01 - 2013-12-31
Lyophilization Technology Consortium for Advanced Manufacturing of Food, Pharmaceuticals and Biotech Products
Sponsor: DOC/National Institute of Standards and Technology (NIST)/Purdue University
Authors: Robin H Bogner
2014-03-01 - 2016-02-29
Solution Mediated Phase Transformation: Investigation Using a Novel Flow-Through Dissolution Apparatus
Sponsor: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation
Authors: Robin H Bogner
2009-01-01 - 2010-05-31